B-type natriuretic peptide for the diagnostic and prognostic assessment in cardiology its interest and perspectives of application;Le peptide B natriurétique pour l'évaluation diagnostique et pronostique en cardiologie: Intérêt pratique et perspectives d'applications

Presse Medicale

Volumn 32, Issue 4, 2003, Pages 181-185

  Meune, Christophe ^a   Fulla, Yvonne ^b   Martins, Edith ^b   Bergmann, Jean François ^b   Devaux, Jean Yves ^b  

^a Institut Cochin   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HYPERTENSION; PROGNOSIS; REVIEW;

ACUTE DISEASE; ANGINA, UNSTABLE; CHRONIC DISEASE; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EMERGENCIES; FEMALE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 0037309641     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. De Bold AJ, Borenstein HB, Veres AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
2. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
3. Hosoda K, Nakao K, Mukoyama M. Expression of brain natriuretic peptide gene in human heart. Hypertension 1991; 17: 1152-6.
4. Mukoyama M, Nakao K, Hosoda K. Brain natriuretic peptide as a novel hormone in humans. J Clin Invest 1991; 87: 1402-12.
5. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Cli Chem Lab Med 2002; 40: 371-7.
6. Wei CM, Heublein DM, Perrella MA et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-9.
7. Maeda K, Tsutamoto T, Wada A, Hissanga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-32.
8. Cowie MR, Struthers AD, Wood DA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 349-53.
9. Cabanes L, Richaud-Thiriez B, Fulla Y et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 2001; 120: 2047-50.
10. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with doppler velocity recording. Circulation 2002; 105: 595-601.
11. Davis M, Espiner E, Richards G, Billings J et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 1994; 343: 440-4.
12. Dao Q, Krishnaswamy P, Kazanegra R et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-85.
13. Maisel AS, Krishnaswamy P, Novak BM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7.
14. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
15. Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T, Hiramori K. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 2002; 87: 131-5.
16. Adachi K, Kawai H, Saito M et al. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy. Intern Med 1997; 36: 497-500.
17. Suzuki T, Hayashi D, Yamazaki T et al. Elevated B-type natriuretic peptide levels after anthracycline administration. Am Heart J 1998; 136: 362-3.
18. Yu CM, Sanderson JE. Plasma brain natriuretic peptide- an independant predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1999; 1: 59-65.
19. Maeda K, Tsutamoto T, Wada A et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587-93.
20. Brunner-La Rocca HP, Weilenmann D, Kiowski W, Maly FE, Candinas R, Follath F. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure. Am Heart J 1999; 138: 654-62.
21. Tsutamoto T, Wada A, Maeda K et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001; 37: 1228-33.
22. Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Riegger GA, Schunkert H. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 1998; 32: 1839-44.
23. Fujimura M, Yasumura Y, Ishida Y et al. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. J Card Fail 2000; 6: 3-10.
24. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-30.
25. Kikuta K, Yasue H, Yoshimura M et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996; 132: 101-7.
26. De Lemos JA, Morrow DA, Bentley JH et al. The prognosis value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
27. Jourdain P, Funck F, Fulla Y et al. B Type natriuretic peptide and cardiac Troponin I in acute chest pain. 4th Intenational congress on coronary artery disease (Prague) 2001.
28. Bettencourt P, Ferreira A, Pardal-Oliveira N et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol 2000; 23: 921-7.
29. Nagaya N, Goto Y, Nishikimi T et al. Sustained elevation of plasma brain natriuretic peptide levels are associated with progressive ventricular remodeling after acute myocardial infarction. Clin Sci 1999; 96: 129-36.
30. Omland T, Aakvaag A, Bonarjee W et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrinatriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-9.
31. Arakawa N, Nakamura M, Endo H, Sugawara S, Suzuki T, Hiramori K. Brain natriuretic peptide and cardiac rupture after acute myocardial infarction. Intern Med 2001; 40: 232-6.
32. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
33. Verdecchia P, Schillaci G, Bragioni C et al. Prognostic significance of serial changes in LV mass in essential hypertension. Circulation 1998; 97: 48-54.
34. Kohno M, Horio T, Yokokawa K et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92: 29-34.
35. Nishikimi T, Yoshihara F, Morimoto A et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
36. Kohno M, Horio T, Yokokava K et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257-65.
37. Talwar S, Downie PF, Squire IB, Davies JE, Barnett DB, Ng LL. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001; 3: 15-9.
38. Nagaya N, Nishikimi T, Uematsu M et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-70.